340Banter Podcast

On this episode of 340Banter, Donovan Smith, CEO of Wayne Community Health Centers, details the real-world impact of the IRA’s Maximum Fair Price (MFP) implementation. He explains how claims are being misattributed to 340B, the challenges of a dual inventory model in a remote pharmacy, the financial strain from denied rebates and low dispensing fees, and the risks to patient access. Donovan also discusses advocacy efforts and potential fixes to make the process fairer for small, rural safety-net providers.

In this episode, we explore a powerful and timely topic: How to reteach yourself how to learn. Whether you’re returning to school, starting a new career, rebuilding confidence, or simply feeling stuck, learning as an adult can feel very different than it did before. The good news? Learning is a skill, and it can be rebuilt. This conversation dives into the mindset shifts, habits, and strategies that help you become a better learner again, especially in a world full of distractions, burnout, and information overload. If you’ve ever thought, “I don’t know how to learn anymore,” this episode is for you. 👉 Subscribe for more conversations on personal growth, mindset, productivity, and lifelong learning.

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho take a closer look at MFP Drugs, the first prescription medications selected for Maximum Fair Price (MFP) under Medicare’s new drug pricing authority. With Medicare now negotiating prices for some of the most widely used and expensive drugs in the U.S., the spotlight is on how these MFP drug selections will affect patients, manufacturers, providers, and the broader healthcare marketplace. Chelsea and Logan break down what it means to be an “MFP drug,” how the negotiation process works, and what stakeholders should be watching as implementation continues. If you work in healthcare policy, pharmacy, drug pricing, Medicare, or 340B compliance, this is a must-listen conversation on one of the biggest shifts in pharmaceutical reimbursement in decades. 👉 Subscribe for more weekly discussions on 340B, Medicare reform, drug pricing policy, and healthcare legislation.

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho break down the latest on Maximum Fair Price (MFP) under the Inflation Reduction Act and ask the big question: How’s it going so far? As Medicare drug price negotiations move from policy theory to real-world implementation, stakeholders across the healthcare system are feeling the impact. Chelsea and Logan unpack what MFP means for drug manufacturers, hospitals, providers, patients, and the 340B program, and explore early reactions, operational challenges, and what comes next. Whether you work in health policy, pharmaceutical pricing, hospital administration, or government affairs, this episode delivers a clear, insightful update on one of the most significant drug pricing reforms in decades. Stay informed on the policies shaping the future of healthcare. 👉 Subscribe to the 340Banter Podcast for weekly insights on 340B, drug pricing reform, healthcare legislation, and pharmaceutical policy.

Running a clinical pharmacy under 340B isn’t just about discounts; it’s about delivering high-quality care and maximizing the program's value. Jamie Kim shares strategies for using 340B savings to expand clinical pharmacy services, improve patient access, and enhance outcomes while remaining compliant. This episode is especially helpful for administrators and pharmacy directors looking to get the most out of 340B.

Accurate UDS reporting is crucial for health centers, but many overlook the role of pharmacy operations and 340B activity in this process. Matthew Krah walks listeners through key considerations for integrating pharmacy and 340B data into Uniform Data System (UDS) reporting. Learn how to ensure your 340B-related prescriptions and savings are properly documented, and avoid common reporting mistakes.

Specialty pharmacies are playing a growing role under 340B, but with that growth comes complexity. Jamie Kim explains how 340B impacts specialty drug distribution, what 340B-eligible health centers need to know before partnering, and where the biggest compliance and financial risks lie. Whether you’re managing a contract pharmacy or overseeing 340B strategy in your organization, this episode offers a must-read roadmap.

Join us as Matt Krah walks through best practices for maintaining a 340B Third-Party Administrator (TPA) program. We cover how TPAs help ensure compliance, manage claims, and streamline contract-pharmacy networks, as well as key red flags to watch out for. If you run or support a 340B covered entity, this episode gives you practical insights to avoid pitfalls and stay audit-ready.

How is provider reporting evolving in today’s 340B environment? Recorded live from the conference floor, this episode of 340Banter brings together co-host Logan Yoho and guest co-host Felicity Homsted to unpack the shifting landscape that covered entities are facing. From new reporting requirements to the impact of technology and data management, this discussion explores the key changes leaders need to understand to stay ahead. Whether you are navigating HRSA audits, managing contracts, or working to keep reporting systems aligned with compliance needs, this episode offers valuable insights for FQHCs and other covered entities. Subscribe to 340Banter for expert insights, transparent conversations, and practical strategies in the FQHC 340B space: https://www.340banter.com  For more resources, visit: https://www.fqhc340b.com

How can milestone moments spark meaningful advocacy and community engagement in the 340B space? Recorded live from the conference floor, this episode of 340Banter features Brenda Reitz, Pharmacy Director at Family Health Services, with co-host Logan Yoho and guest host Felicity Homsted. Brenda shares how her organization’s 20th anniversary celebration became more than a milestone—it became a catalyst for advocacy, relationship building, and deeper community connections. From aligning staff around a shared mission to engaging policymakers and patients, this conversation highlights how covered entities can use key events to amplify their impact. Whether you are planning a major organizational milestone or simply looking for fresh ways to energize your advocacy efforts, this episode offers practical inspiration. Subscribe to 340Banter for real-world insights, transparent conversations, and practical strategies in the FQHC 340B space: https://www.340banter.com  For more resources, visit: https://www.fqhc340b.com 

What surprises are covered entities facing in HRSA-approved manufacturer audits today? Recorded live from the conference floor, this episode of 340Banter features Madeline Wallack, Founder of Rx|X Consulting & Avanti340B, alongside co-host Logan Yoho and guest host Felicity Homsted. Together, they share real-world insights from the frontlines of manufacturer audits and discuss how FQHCs and other covered entities can stay prepared. From unexpected documentation requests to evolving audit practices, this candid conversation explores the key issues that leaders may not see coming. Whether you are new to audits or have weathered several rounds, the lessons here can help strengthen your compliance strategy. Subscribe to 340Banter for transparent conversations and practical strategies in the FQHC 340B space: https://www.340banter.com  For more resources, visit: https://www.fqhc340b.com 

What does the new 340B Rebate Model Pilot mean for FQHCs and covered entities navigating today’s 340B landscape? In this episode of 340Banter, co-host Logan Yoho and guest host Felicity Homsted break down the details of this evolving initiative and what it could mean for compliance, program savings, and manufacturer relationships. From understanding the intent of the pilot to anticipating potential impacts on pharmacy operations, this conversation delivers clarity on a complex but critical change in the 340B world. If you’ve been wondering how rebate models may reshape covered entity strategies, this is the episode for you. 🎧 Stay ahead of the curve on 340B policy shifts—learn what the rebate pilot means and how to prepare your organization. Subscribe to 340Banter for expert insights, transparent conversations, and practical strategies in the FQHC 340B space: https://www.340banter.com  For more resources, visit: https://www.fqhc340b.com

How can you stay compliant while managing the growing complexity of 340B programs? In Episode 15 of 340Banter, Charnay Ingram and LaNika Ellis share proven oversight strategies that keep their programs running smoothly and audit-ready. From tracking changes to engaging internal stakeholders, this episode offers practical, scalable tips that every 340B leader needs to hear—whether you're overseeing a large system or a single-site FQHC. What You’ll Learn: Core elements of strong 340B oversight How to build workflows that prevent compliance gaps Tips for engaging your pharmacy, finance, and clinical teams Real examples of oversight wins and lessons learned 🎧 Take the stress out of 340B oversight—learn how to build a strong foundation that lasts. Subscribe to 340Banter for transparent conversations and field-tested strategies: https://www.340banter.com For more information, visit: https://www.fqhc340b.com/

What’s driving the surge in state contract pharmacy protection laws—and how does a 340B-related bill actually become a law? In Episode 14 of 340Banter, co-hosts Chelsea Violette and Logan Yoho break it all down with clarity, insight, and real-world relevance. Whether you're advocating for change, tracking legislation, or trying to understand your state’s protections, this episode gives you the foundational knowledge and strategic context you need. What You’ll Learn: Why states are passing contract pharmacy protection laws The step-by-step process of how a bill becomes law Key players, timelines, and advocacy tips How 340B stakeholders can influence policy outcomes 🎧 Stay informed and proactive—this episode is your roadmap to understanding the evolving legal landscape of 340B. Subscribe to 340Banter for expert guidance and real-world discussions: https://www.340banter.com For more information visit: https://www.fqhc340b.com/ 

How do 340B professionals grow, pivot, and thrive in this complex program space? In Episode 13 of the 340Banter Podcast, Chris Christian and LaNika Ellis share their inspiring and unconventional career journeys within the 340B world—from clinic operations to program management and advocacy. Whether you're new to 340B or a seasoned professional looking to grow your role, this conversation is filled with relatable stories, practical advice, and encouragement for anyone navigating the evolving 340B landscape. What You’ll Learn: How Chris and LaNika found their way into 340B The transferable skills that matter most in this field Tips for advancing your 340B career at any stage 🎧 Ready to build your path in 340B? Don’t miss this empowering episode with two passionate leaders paving the way. Subscribe to 340Banter for expert advice, real-world stories, and community-driven insights: https://www.340banter.com For more information, visit: https://www.fqhc340b.com/

What really happens during a 340B HRSA audit? In Episode 12 of 340Banter, Richard Cox from Hope Family Health and Chris Christian from FQHC 340B Compliance walk us through their firsthand audit experience, sharing what worked, what they learned, and how they stayed prepared every step of the way. Whether you're facing an upcoming HRSA audit or just want to strengthen your 340B compliance practices, this transparent, behind-the-scenes episode is packed with actionable advice from those who’ve been through it. What You’ll Learn: -How to prepare for a HRSA 340B audit -What documentation is critical to have ready -Communication tips during the audit process -Real-world takeaways from an FQHC’s audit journey 🎧 Don’t go into your next HRSA audit blind—get insider insights now! Subscribe to 340Banter for more expert tips and real-world stories: https://www.340banter.com For more information, visit: https://www.fqhc340b.com/ 

In this episode of 340Banter, Rhiannon Klein shares grounded, real-world strategies for building an impactful advocacy presence. Drawing from her experience leading Community Voice of 340B, she discusses how to mobilize communities, craft compelling messages, and stay resilient in the face of challenges. Tune in for clear, actionable guidance on becoming a more confident and effective advocate in the 340B space.

In this episode of 340Banter, Derek Pihl, PharmD, shares key takeaways from his advocacy work at both the state and federal levels. From building legislative relationships to navigating challenges in public health policy, Derek offers lessons learned and strategies for effective 340B engagement. Tune in for practical insights, inspiring stories, and actionable advice to help you make a meaningful impact in the advocacy space.

In this practical and perspective-rich episode, co-hosts Chelsea Violette and Logan Yoho sit down with Michael Gonzalez of FQHC 340B Compliance to talk all things vendors—how to evaluate them, collaborate effectively, and avoid common pitfalls. Michael shares his expert take on what makes a strong vendor relationship, the red flags to watch for, and how FQHCs can ensure vendors are aligned with compliance, performance, and mission. If you’re working with—or thinking about working with—340B vendors, this episode is your go-to guide for making smart, strategic choices. 

In this eye-opening episode, co-hosts Chelsea Violette and Logan Yoho sit down with Felicity Homsted, CEO of FQHC 340B Compliance, to unpack one of the most pressing issues facing the 340B community today—manufacturer restrictions. Felicity brings a data-driven, policy-informed perspective to the conversation, shedding light on how these restrictions impact patient care, covered entities, and the integrity of the program itself. Tune in as she breaks down the evolving manufacturer landscape, shares compliance strategies, and explores what advocacy efforts are gaining traction. If you’ve felt the squeeze of manufacturer limitations, this episode offers clarity, context, and a call to action.

Join co-hosts Chelsea Violette and Logan Yoho for a media-savvy deep dive with Ted Slafsky, founder and publisher of 340B Report, as they break down the latest headlines shaping the 340B world. From legislative developments to court rulings and industry shake-ups, Ted brings his insider perspective and journalistic expertise to help listeners make sense of the noise. Whether you're trying to stay current or understand how media narratives influence policy and practice, this episode delivers sharp analysis, timely updates, and behind-the-scenes insights you won’t find anywhere else.

Co-hosts Chelsea Violette and Logan Yoho are joined by special guest Michael Gonzalez, founder of FQHC 340B Compliance, for a candid conversation on breaking into and building a career in the 340B space. In “Finding Your Footing in 340B: Career Stories & Strategies,” Michael shares his journey from accountant to entrepreneur, the inspiration behind launching his own compliance-focused firm, and the key lessons he's learned along the way. Whether you're just starting out or looking to level up in your 340B career, this episode delivers real talk, actionable advice, and the kind of insight you won't find in a textbook.

Co-hosts Chelsea Violette and Logan Yoho dive into the strategy behind building in-house pharmacies in “340B & Entity-Owned Pharmacies: What to Know Before You Start.” Joined by special guest Michael Gonzalez, Founder of FQHC 340B Compliance, this episode unpacks the why, how, and what's next for entity-owned pharmacies in the 340B space. From startup considerations to operational tips and compliance must-knows, it’s a conversation filled with practical advice, strategic insights, and forward-looking perspectives for covered entities looking to take control of their pharmacy footprint. Don’t miss this expert-led roadmap to unlocking the full potential of in-house dispensing.

Co-hosts Chelsea Violette and Logan Yoho take you inside the courtroom in "340B Key Legal Arguments & Future Trends" with special guests Mark Ogunsusi and Jason Reddish of Powers Law. From landmark cases to ongoing legal battles, this episode explores the different arguments manufacturers are using to make their case and what it means for stakeholders across the board. Tune in for a dynamic conversation packed with legal insight, real-world implications, and expert analysis you won't want to miss.

Co-hosts Chelsea Violette and Logan Yoho dive into "Finding Your Place in 340B" with special guest Michael Gonzalez, Founder of FQHC 340B Compliance. From career journeys to industry insights, this episode unpacks the many paths within 340B and how you can carve out your own. Don't miss this engaging conversation. 

In this episode, we dive into the critical topic of patient definition and the responsibility of care for 340B Covered Entities. Tune in as we discuss the complexities of responsibility of care and how covered entities like FQHCs can navigate their responsibility to provide accessible, high-quality care while staying compliant.